Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Pavone, Luigi (56659204600)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity
    (2022)
    Gilio, Luana (57199416221)
    ;
    Buttari, Fabio (6506634010)
    ;
    Pavone, Luigi (56659204600)
    ;
    Iezzi, Ennio (23469684200)
    ;
    Galifi, Giovanni (57271435700)
    ;
    Dolcetti, Ettore (57195302892)
    ;
    Azzolini, Federica (57211460988)
    ;
    Bruno, Antonio (57059889100)
    ;
    Borrelli, Angela (57210320896)
    ;
    Storto, Marianna (7003476426)
    ;
    Furlan, Roberto (7005770529)
    ;
    Finardi, Annamaria (36672897300)
    ;
    Pekmezovic, Tatjana (7003989932)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Mandolesi, Georgia (6508313559)
    ;
    Fresegna, Diego (40461316400)
    ;
    Vanni, Valentina (35575070000)
    ;
    Centonze, Diego (57200217993)
    ;
    Stampanoni Bassi, Mario (44360890200)
    In multiple sclerosis (MS), fatigue is a frequent symptom that negatively affects quality of life. The pathogenesis of fatigue is multifactorial and inflammation may play a specific role. To explore the association between fatigue, central inflammation and disease course in MS in 106 relapsing-remitting (RR)-MS patients, clinical characteristics, including fatigue and mood, were explored at the time of diagnosis. NEDA (no evidence of disease activity)-3 status after one-year follow up was calculated. Cerebrospinal fluid (CSF) levels of a set of proinflammatory and anti-inflammatory molecules and peripheral blood markers of inflammation were also analyzed. MRI structural measures were explored in 35 patients. A significant negative correlation was found at diagnosis between fatigue measured with the Modified Fatigue Impact Scale (MFIS) and the CSF levels of interleukin (IL)-10. Conversely, no significant associations were found with peripheral markers of inflammation. Higher MFIS scores were associated with reduced probability to reach NEDA-3 status after 1-year follow up. Finally, T2 lesion load showed a positive correlation with MFIS scores and a negative correlation with CSF IL-10 levels at diagnosis. CSF inflammation, and particularly the reduced expression of the anti-inflammatory molecule IL-10, may exacerbate fatigue. Fatigue in MS may reflect subclinical CSF inflammation, predisposing to greater disease activity. © 2022 by the authors.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity
    (2022)
    Gilio, Luana (57199416221)
    ;
    Buttari, Fabio (6506634010)
    ;
    Pavone, Luigi (56659204600)
    ;
    Iezzi, Ennio (23469684200)
    ;
    Galifi, Giovanni (57271435700)
    ;
    Dolcetti, Ettore (57195302892)
    ;
    Azzolini, Federica (57211460988)
    ;
    Bruno, Antonio (57059889100)
    ;
    Borrelli, Angela (57210320896)
    ;
    Storto, Marianna (7003476426)
    ;
    Furlan, Roberto (7005770529)
    ;
    Finardi, Annamaria (36672897300)
    ;
    Pekmezovic, Tatjana (7003989932)
    ;
    Drulovic, Jelena (55886929900)
    ;
    Mandolesi, Georgia (6508313559)
    ;
    Fresegna, Diego (40461316400)
    ;
    Vanni, Valentina (35575070000)
    ;
    Centonze, Diego (57200217993)
    ;
    Stampanoni Bassi, Mario (44360890200)
    In multiple sclerosis (MS), fatigue is a frequent symptom that negatively affects quality of life. The pathogenesis of fatigue is multifactorial and inflammation may play a specific role. To explore the association between fatigue, central inflammation and disease course in MS in 106 relapsing-remitting (RR)-MS patients, clinical characteristics, including fatigue and mood, were explored at the time of diagnosis. NEDA (no evidence of disease activity)-3 status after one-year follow up was calculated. Cerebrospinal fluid (CSF) levels of a set of proinflammatory and anti-inflammatory molecules and peripheral blood markers of inflammation were also analyzed. MRI structural measures were explored in 35 patients. A significant negative correlation was found at diagnosis between fatigue measured with the Modified Fatigue Impact Scale (MFIS) and the CSF levels of interleukin (IL)-10. Conversely, no significant associations were found with peripheral markers of inflammation. Higher MFIS scores were associated with reduced probability to reach NEDA-3 status after 1-year follow up. Finally, T2 lesion load showed a positive correlation with MFIS scores and a negative correlation with CSF IL-10 levels at diagnosis. CSF inflammation, and particularly the reduced expression of the anti-inflammatory molecule IL-10, may exacerbate fatigue. Fatigue in MS may reflect subclinical CSF inflammation, predisposing to greater disease activity. © 2022 by the authors.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback